Hojat Askari
Internal Medicine · Prescott, AZNPI 1326251695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $540 and has fallen 95.7% since, to $23 in 2023.
Across 90 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$252
- E.r. Squibb & Sons, L.L.C.$121
- GSK$109
- AstraZeneca$89
- Amgen$75
- Lucid Diagnostics Inc.$71
- plus $871 from 32 others
What the payments were for
- Food & beverage$1,590100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $252 |
| E.r. Squibb & Sons, L.L.C. | 8 | $121 |
| GSK | 7 | $109 |
| AstraZeneca | 7 | $89 |
| Amgen(2 entities) | 5 | $75 |
| Lucid Diagnostics Inc. | 3 | $71 |
| Abbott | 3 | $69 |
| Stryker | 1 | $59 |
| Radius Health, Inc. | 3 | $57 |
| Angiodynamics, Inc. | 1 | $54 |
| Amarin Pharma, Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $45 |
| Novo Nordisk | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $32 |
| Phadia US Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $31 |
| Tactile Systems Technology Inc | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 1 | $29 |
| Kaleo, Inc. | 1 | $28 |
| Johnson & Johnson | 2 | $28 |
| Boehringer Ingelheim | 1 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Pfizer | 2 | $25 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Team_makena_llc | 1 | $14 |
| GE HealthCare | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Biogen | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Boston Scientific | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,590 in reported general payments places this provider in the 80th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Prescott
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Kelly KrohnPhoenix$262K
- Jacque SokolovScottsdale$235K
- Paul StanderPhoenix$222K
- Howard GrossmanPhoenix$131K
- Christine HarterGlendale$127K
- Nafis Shamsid-DeenPhoenix$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.